US considers establishing behind-the-counter drugs

Shuchman, Miriam
January 2008
CMAJ: Canadian Medical Association Journal;1/29/2008, Vol. 178 Issue 3, p272
Academic Journal
The article reports on the consideration of the Food and Drug Administration (FDA) in the U.S. about approving a new class of drugs for behind-the-counter sales that is similar to the Canadian category of the drugs. According to FDA spokesperson Chris Kelly, the agency wants to know the perspective of the Canadian government from the country's experience concerning the behind-the-counter drugs. The American pharmacists have supported the plan but have demanded a new scheme for payment, while the Medical Association and other medical groups have strongly opposed the idea.


Related Articles

  • New options for patients with allergies, overactive bladders. TANZI, MARIA G. // Pharmacy Today;Feb2014 OTC Supplement, p4 

    The article reports on the approval of the U.S. Food and Drug Administration (FDA) of two over-the-counter drugs for patients with allergies and overactive bladders, the triamcinolone acetonide nasal spray and oxybutynin transdermal system. It looks at the concerns of FDA Nonprescription Drugs...

  • FDA's OTC-plus concept: 'Yes … if'. Menighan, Thomas E. // Pharmacy Today;Apr2012, Vol. 18 Issue 4, p14 

    The article focuses on the initiative created by the U.S. Food and Drug Administration (FDA) which could provide a tool for pharmacists to help them in patient care. It mentions that the FDA's Over-the-Counter (OTC) concept would make some drugs be available to patients without prescription,...

  • News Briefs.  // American Journal of Health-System Pharmacy;3/1/2008, Vol. 65 Issue 5, p388 

    The article offers news briefs related to the pharmaceutical industry in the U.S. as of March 1, 2008. Merck & Co. Inc. announced that the Food and Drug Administration (FDA) turned down its third request to market a non-prescription version of lovastatin. Pharmacist John A. Viercinski died at...

  • Oxytrol for Women Now OTC.  // Monthly Prescribing Reference;Mar2013, Vol. 29 Issue 3, pA-13 

    The article informs that U.S. Food & Drug Administration (FDA) has approved drug Oxytrol for women, the first over-the-counter (OTC) treatment for overactive bladder in women.

  • Q & A Future of OTC.  // Drug Store News;3/17/2014, Vol. 36 Issue 3, p22 

    The article presents questions and answers related to over-the-counter (OTC) drugs in the U.S., the progress in making OTCs eligible for the U.S. Food and Drug Administration and the key opportunities for the OTC industry.

  • OTC.  // Drug Topics;10/6/2003, Vol. 147 Issue 19, p116 

    Features various over-the-counter drugs approved by the U.S. Food and Drug Administration as of October 2003. PrimaVu Herbal Eye Drops from Prima Vu Health Care; Sierra Medicinals' Dr. Steven Rosenblatt's Starch Blocker.

  • Sanofi-aventis' Allegra to Go O-T-C.  // MMR;2/7/2011, Vol. 28 Issue 3, p16 

    The article reports about the U.S. Food and Drug Administration's approval of an allergy medication Allegra-D for over-the-counter use.

  • Members Are Talking ….  // Pharmacy Today;Jul2012, Vol. 18 Issue 7, p32 

    An excerpt from the American Pharmacists Association (APhA) members-only e-Community discussion on the proposed over-the-counter (OTC)+ category of the U.S. Food and Drug Administration (FDA) is presented.

  • Expanding the availability of OTC medication. Bell, Edward A. // Infectious Diseases in Children;May2012, Vol. 25 Issue 5, p12 

    The article reports that the U.S. Food and Drug Administration (FDA) is considering allowing the establishment of some medications to be available over-the-counter (OTC) following the use of specific electronic diagnostic measures or algorithms, or after consultation with a pharmacist.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics